Comments
Drug firm Alkem Laboratories on Friday reported a 13.58 per cent rise in its consolidated net profit to Rs 205.45 crore for the quarter ended December 31, 2018.
The company had posted a net profit of Rs 180.87 crore for the corresponding period of the previous fiscal, Alkem Laboratories said in a filing to BSE.
Consolidated revenue from operations of the company stood at Rs 1,925.03 crore for the quarter under consideration as against Rs 1,741.19 crore for the same period a year ago.
The company’s board has declared an interim dividend of Rs 8 per equity share of the face value of 2 each, Alkem Laboratories said.
Shares of the company were trading at Rs 1,893.50 per scrip on BSE, up 0.57 per cent from its previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.